or Try an Advanced Search...

    Technical Analysis for RVPH - Reviva Pharmaceuticals Holdings, Inc.

    Grade Last Price % Change Price Change
    F 2.82 0.71% 0.02
    RVPH closed up 0.71 percent on Wednesday, May 8, 2024, on approximately normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    Earnings due: May 13
    *** please verify all earnings dates ***
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical RVPH trend table...
    Date Alert Name Type % Chg
    20 DMA Resistance Bearish 0.00%
    Pocket Pivot Bullish Swing Setup 0.00%
    Doji - Bullish? Reversal 0.00%
    Stochastic Reached Oversold Weakness 0.00%
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    MACD Bearish Signal Line Cross Bearish 0.71%
    Wide Bands Range Expansion 0.71%
    Wide Bands Range Expansion -4.08%
    20 DMA Resistance Bearish -11.88%
    Older End-of-Day Signals for RVPH ...

       Recent Intraday Alerts

    Alert Time
    10 DMA Resistance about 11 hours ago
    Rose Above 20 DMA about 11 hours ago
    20 DMA Resistance about 11 hours ago
    Up 10% about 11 hours ago
    Rose Above Previous Day's High about 12 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    RVPH Chart by TradingView
    Basic chart:

    Profile

    Reviva Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops therapies to address unmet medical needs in the areas of central nervous system, cardiovascular, metabolic, and inflammatory diseases. Its lead product candidate is RP5063 for the treatment of schizophrenia, bipolar disorder, and major depressive disorder, as well as for treating pulmonary arterial hypertension and idiopathic pulmonary fibrosis. The company is based in Cupertino, California.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Drugs Inflammatory Diseases Schizophrenia Psychiatric Diagnosis Psychiatry Major Depressive Disorder Stage Pharmaceutical Idiopathic Pulmonary Fibrosis Pulmonary Arterial Hypertension Pulmonary Fibrosis Chloroarenes Bipolar Disorder Pulmonary Hypertension Treatment Of Schizophrenia Piperazines

    Is RVPH a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 25 RVPH: Full Year 2023 Results
    Apr 15 Reviva Pharmaceuticals FY Non-GAAP EPS of -$1.65 beats by $0.01
    Apr 15 Reviva reports FDA acceptance of 4-week RECOVER-2 study for its schizophrenia treatment
    Apr 15 Reviva Announces FDA Alignment on Brilaroxazine Clinical Trials for NDA in Schizophrenia
    Apr 15 Reviva Reports Full Year 2023 Financial Results and Recent Business Highlights
    Apr 15 RVPH: Update to Brilaroxazine Safety vs. Efficacy Comparison – Adding RECOVER Data
    Mar 28 Reviva to Present RECOVER Phase 3 Clinical Trial Data for Brilaroxazine in Schizophrenia at the SIRS 2024 Annual Meeting
    Mar 26 Reviva to Present RECOVER Phase 3 Clinical Trial Data for Brilaroxazine in Schizophrenia at the ASCPT 2024 Annual Meeting
    Mar 11 Reviva to Present at the UBS Virtual CNS Day
    Mar 7 Reviva to Present at the 36th Annual ROTH Conference
    See more RVPH news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 8.61
    52 Week Low 2.67
    Average Volume 247,905
    200-Day Moving Average 4.17
    50-Day Moving Average 3.33
    20-Day Moving Average 3.14
    10-Day Moving Average 3.01
    Average True Range 0.25
    RSI (14) 37.11
    ADX 18.27
    +DI 17.70
    -DI 24.05
    Chandelier Exit (Long, 3 ATRs) 3.06
    Chandelier Exit (Short, 3 ATRs) 3.55
    Upper Bollinger Bands 3.66
    Lower Bollinger Band 2.63
    Percent B (%b) 0.19
    BandWidth 32.74
    MACD Line -0.14
    MACD Signal Line -0.13
    MACD Histogram -0.0158
    Fundamentals Value
    Market Cap 78.73 Million
    Num Shares 27.9 Million
    EPS -1.68
    Price-to-Earnings (P/E) Ratio -1.68
    Price-to-Sales 0.00
    Price-to-Book 69.86
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 3.39
    Resistance 3 (R3) 3.45 3.31 3.30
    Resistance 2 (R2) 3.31 3.17 3.29 3.26
    Resistance 1 (R1) 3.07 3.08 3.00 3.01 3.23
    Pivot Point 2.93 2.93 2.90 2.91 2.93
    Support 1 (S1) 2.69 2.79 2.62 2.63 2.41
    Support 2 (S2) 2.55 2.70 2.53 2.38
    Support 3 (S3) 2.31 2.55 2.35
    Support 4 (S4) 2.25